19-10352559-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003331.5(TYK2):​c.3201-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0023 in 1,457,160 control chromosomes in the GnomAD database, including 89 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 82 hom. )

Consequence

TYK2
NM_003331.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00006729
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.171

Publications

1 publications found
Variant links:
Genes affected
TYK2 (HGNC:12440): (tyrosine kinase 2) This gene encodes a member of the tyrosine kinase and, more specifically, the Janus kinases (JAKs) protein families. This protein associates with the cytoplasmic domain of type I and type II cytokine receptors and promulgate cytokine signals by phosphorylating receptor subunits. It is also a component of both the type I and type III interferon signaling pathways. As such, it may play a role in anti-viral immunity. A mutation in this gene has been associated with Immunodeficiency 35. [provided by RefSeq, Sep 2020]
TYK2 Gene-Disease associations (from GenCC):
  • immunodeficiency 35
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-10352559-G-A is Benign according to our data. Variant chr19-10352559-G-A is described in ClinVar as Benign. ClinVar VariationId is 259044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0517 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TYK2NM_003331.5 linkc.3201-8C>T splice_region_variant, intron_variant Intron 22 of 24 ENST00000525621.6 NP_003322.3 P29597A0A024R7E4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TYK2ENST00000525621.6 linkc.3201-8C>T splice_region_variant, intron_variant Intron 22 of 24 1 NM_003331.5 ENSP00000431885.1 P29597

Frequencies

GnomAD3 genomes
AF:
0.00257
AC:
391
AN:
152010
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.0567
Gnomad SAS
AF:
0.00436
Gnomad FIN
AF:
0.00236
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000500
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00600
AC:
1146
AN:
190948
AF XY:
0.00589
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.000416
Gnomad EAS exome
AF:
0.0597
Gnomad FIN exome
AF:
0.00286
Gnomad NFE exome
AF:
0.000828
Gnomad OTH exome
AF:
0.00335
GnomAD4 exome
AF:
0.00227
AC:
2965
AN:
1305032
Hom.:
82
Cov.:
20
AF XY:
0.00231
AC XY:
1492
AN XY:
644708
show subpopulations
African (AFR)
AF:
0.0000673
AC:
2
AN:
29712
American (AMR)
AF:
0.000114
AC:
4
AN:
35098
Ashkenazi Jewish (ASJ)
AF:
0.00101
AC:
21
AN:
20732
East Asian (EAS)
AF:
0.0545
AC:
2019
AN:
37036
South Asian (SAS)
AF:
0.00264
AC:
193
AN:
73026
European-Finnish (FIN)
AF:
0.00303
AC:
152
AN:
50212
Middle Eastern (MID)
AF:
0.000191
AC:
1
AN:
5236
European-Non Finnish (NFE)
AF:
0.000411
AC:
411
AN:
999820
Other (OTH)
AF:
0.00299
AC:
162
AN:
54160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.541
Heterozygous variant carriers
0
143
286
430
573
716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00258
AC:
392
AN:
152128
Hom.:
7
Cov.:
32
AF XY:
0.00316
AC XY:
235
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41506
American (AMR)
AF:
0.000197
AC:
3
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.0570
AC:
295
AN:
5174
South Asian (SAS)
AF:
0.00436
AC:
21
AN:
4818
European-Finnish (FIN)
AF:
0.00236
AC:
25
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000500
AC:
34
AN:
67978
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.524
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000634
Hom.:
0
Bravo
AF:
0.00315
Asia WGS
AF:
0.0230
AC:
81
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 13, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Immunodeficiency 35 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.45
DANN
Benign
0.54
PhyloP100
-0.17
PromoterAI
-0.010
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000067
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304252; hg19: chr19-10463235; COSMIC: COSV53386878; COSMIC: COSV53386878; API